Vontobel Financial Products GmbH (F28903) Quote

nice

Shareholders predictions

Reduced to fallacies ;) , ho hum.......Its a real problem with social media, left or right......

'Bonus' version= cell therapy products manufactured in the Sawston facility may be exported globally.
Under this commercial manufacturing license, cell therapy products manufactured in the Sawston facility may be exported globally. Products (e.g., immune cells) may also be imported into the U

nice

Nice run a while back

LOLOLOLOLISSIMO!! I hope Kamala thanks him for it!

Excellent!

someone spent 2 dollars wow something must be going on

When the final distribution is announced when theirs no more lawsuits, you’ll admit I was right then

It has nothing to do with our approval. Completely irrelevant

Wonder if this has anything to do with Digital Utilities Ventures now.

Not that I heard, just bouncing all over

Wonder if they can keep the momentum

Great numbers

Maybe billion

Wonder billions market capitalization down the road

So sadly true!

Fink,
What's the upside potential from here? GPLS$

Always good to start somewhere. I’d remove vigabatrin altogether and cut markets for Vyvanse and OxyContin in half as they shift from brand to generic with competitors. To offset this, I’d also model a more generous market capture. Let’s see that Vyvanse or OxyContin approval first

Crunchbase has Rohan Chanmugam holds 2 board and advisor roles as Board Director at OneMind Technologies and Board Director at Affluence Corporation.

Which we all may have assumed anyway

From what we know he is the acting CEO of OneMind until they get a new replacement